Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $4.6450 (-15%) ($4.4100 - $4.6450) on Thu. Sep. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.58% (three month average) | RSI | 17 | Latest Price | $4.6450(-15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -3.9% a day on average for past five trading days. | Weekly Trend | IOVA declines -4.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) SHY(81%) GDX(65%) GDXJ(64%) IPO(64%) SLV(57%) | Factors Impacting IOVA price | IOVA will decline at least -2.29% in a week (0% probabilities). XRT(-38%) XME(-42%) XLV(-28%) ICLN(-34%) XLP(-32%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.29% (StdDev 4.58%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-5.82(-225.3%) | Resistance Level | $5.98 | 5 Day Moving Average | $5.61(-17.2%) | 10 Day Moving Average | $5.78(-19.64%) | 20 Day Moving Average | $5.98(-22.32%) | To recent high | -46.7% | To recent low | 0% | Market Cap | $680m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |